Resources from the same session
What defines “born to be bad” cancers?
Presenter: Nicholas McGranahan
Session: Hard-to-treat cancers: What makes them special?
Resources:
Slides
Webcast
Small cell lung cancer: How molecular insights have shed light on aggressive clinical behaviour
Presenter: Charles Rudin
Session: Hard-to-treat cancers: What makes them special?
Resources:
Slides
Webcast
Dissecting response to treatment in adult patients with a glioma
Presenter: Roel Verhaak
Session: Hard-to-treat cancers: What makes them special?
Resources:
Slides
Webcast
How can we accelerate drug discovery and development for patients with hard-to-treat cancers?
Presenter: Elena Garralda
Session: Hard-to-treat cancers: What makes them special?
Resources:
Slides
Webcast